Corundum Trust Company’s Eli Lilly LLY Stock Holding History

Corundum Trust Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	1,095 +19	+2%	+$19.3K	2.3%	14
2025 Q4	$1.16M	Sell	1,076 -24	-2%	-$22.9K	2.63%	13
2025 Q3	$839K	Sell	1,100 -2	-0.2%	-$1.49K	1.82%	14
2025 Q2	$859K	Sell	1,102 -43	-4%	-$33.4K	2.27%	13
2025 Q1	$946K	Sell	1,145 -33	-3%	-$27.5K	2.73%	11
2024 Q4	$909K	Sell	1,178 -27	-2%	-$22.4K	2.73%	11
2024 Q3	$1.07M	Sell	1,205 -133	-10%	-$120K	2.94%	10
2024 Q2	$1.21M	Buy	+1,338	New	+$1.07M	3.52%	9
2023 Q3	$1.48M	Sell	2,747 -5	-0.2%	-$2.58K	4.41%	9
2023 Q2	$1.29M	Buy	+2,752	New	+$1.15M	3.53%	10

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Corundum Trust Company's LLY Position: Q1 2026 in Review

Corundum Trust Company increased its Eli Lilly (LLY) stake by 1.8% in Q1 2026, buying an estimated $19.3K and bringing the position to 1,095 shares worth $1.01M. The position accounts for 2.3% of the portfolio, ranked #14.

Corundum Trust Company first reported a position in LLY in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.48M in Q3 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Corundum Trust Company held 1,095 shares of Eli Lilly worth $1.01M as of Q1 2026.
Corundum Trust Company bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
Eli Lilly made up 2.3% of Corundum Trust Company's portfolio in Q1 2026, its #14 holding.
Corundum Trust Company first reported a position in Eli Lilly in Q2 2023 and has held it in 10 quarters since.
Corundum Trust Company's Eli Lilly position peaked at $1.48M in Q3 2023.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Corundum Trust Company's 13F filing for Q1 2026, filed 15 Apr 2026.